Correlation between the key factor of NGAL pathway and recurrence of ulcerative colitis and its clinical application
-
摘要: [目的]探究NGAL通路关键因子与溃疡性结肠炎复发的相关性研究及临床应用。[方法]随机收集我院收治的89例溃疡性结肠炎患者,根据其严重程度分为轻、中度UC组与重度UC组,分别检测患者体内的NGAL通路关键因子水平,并对比分析两组患者治疗缓解后的复发情况。[结果]治疗前重度UC组患者的血清NGAL水平明显高于轻、中度UC组患者,差异有统计学意义(P<0.05)。治疗后重度UC组患者的血清NGAL水平与轻、中度UC组患者相比未见明显差异(P>0.05)。治疗缓解患者重度UC组停药后3个月、停药后6个月的复发率明显高轻、中度UC组患者,差异有统计学意义(P<0.05)。[结论]NGAL水平在溃疡性结肠炎患者中明显升高,且疾病活动程度越高,其NGAL水平升高越明显,患者的复发率也随之升高,控制患者NGAL水平,有利于预防疾病复发,具有重要临床意义。
-
关键词:
- NGAL通路关键因子 /
- 溃疡性结肠炎 /
- 复发 /
- 相关性
Abstract: [Objective]To study the correlation between the key factor of NGAL pathway and the recurrence of ulcerative colitis and its clinical application.[Methods]89 patients with ulcerative colitis were randomly selected.According to the severity of ulcerative colitis,the patients were divided into mild and moderate UC group and severe UC group.The levels of NGAL pathways in the patients were detected,and the relapse rate of the two groups was analyzed retrospectively.[Results]Serum NGAL levels in patients with severe UC were significantly higher than those in patients with mild to moderate UC(P<0.05).The recurrence rate of severe UC group was significantly higher than that of moderate UC group at 3 months and 6 months after remission(P<0.05).[Conclusion]The level of NGAL in patients with ulcerative colitis was significantly increased.And the higher the degree of disease activity,the more obvious NGAL levels increased.At the same time the recurrence rate of patients was also increased,It may have important clinical significance to control the levels of NGAL in patients with UC for prevention of disease recurrence.-
Key words:
- NGAL pathway key factor /
- Ulcerative colitis /
- Relapse /
- Correlation
-
-
[1] 李宝全, 安翠平, 赵小洁, 等.溃疡性结肠炎患者血清NGAL检测及意义[J].标记免疫分析与临床, 2015, 22 (2):113-115.
[2] 刘晓昌, 梅俏, 黄健, 等.溃疡性结肠炎患者小肠黏膜通透性改变及其机制研究[J].中华消化杂志, 2013, 33 (8):559-561.
[3] 中华医学会消化病学分会炎症性肠病学组.炎症性肠病诊断与治疗的共识意见 (2012年广州)[J].中华消化杂志, 2012, 32 (12):796-813.
[4] 王艳, 李俊霞, 王化虹, 等.溃疡性结肠炎肠道菌群失调与免疫球蛋白水平的相关性[J].实用医学杂志, 2016, 32 (10):1631, 1634.
[5] Denmark VK, Mayer L.Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease:an update[J].Expert Rev Clin Immunol, 2013, 9 (1):77-92.
[6] 朱娟, 刘志峰.溃疡性结肠炎患儿血清炎症因子及氧化应激水平变化及意义[J].现代中西医结合杂志, 2016, 25 (14):1492-1494, 1498.
[7] 蒋继周, 金一, 郑舒丹.外周血中MMP-2、MMP-9与溃疡性结肠炎患者肠黏膜通透性的相关性分析[J].胃肠病学和肝病学杂志, 2015, 24 (11):1387-1389.
[8] Lindberg S, Jensen J S, Mogelvang R, et al.Plasma neutrophil gelatinase-associated lipocalinin in the general population:association with inflammation and prognosis[J].A rterioscler Thromb Vasc Biol, 2014, 34 (9):2135-2142.
[9] 朱玉, 赵孝文, 丁浩, 等.溃疡性结肠炎患者粪便中Cal、MMP-9、MPO水平检测的临床研究[J].安徽医科大学学报, 2015, 50 (6):847-849, 854.
[10] Kopylov U, Rosenfeld G, Bressler B, et al.Clinical utility of fecal biomarkers for the diagnosis and management of inflammatory bowel disease[J].Inflamm Bowel Dis, 2014, 20 (4):742-56.
[11] 杨卫文, 黎莉, 谭松, 等.溃疡性结肠炎缓解期肠道粘膜低度炎性反应与复发的关系[J].贵州医药, 2015, 39 (8):734, 736.
[12] 丁磊, 张秀峰, 张延祥, 等.结直肠癌患者血清中性粒细胞明胶酶相关载脂蛋白检测的临床意义[J].中华胃肠外科杂志, 2014, 17 (6):589-593.
[13] 徐希, 陈卫昌, 朱一凡, 等.胃癌患者血清MMP-9、NGAL水平及其临床意义[J].胃肠病学, 2014, 19 (8):468-471.
[14] FREHN L, JANSENA, BENNEK E, et al.Distinct patterns of IgG and IgA against food and microbial antigens in serum and Feces of patients with inflammatory bowel diseases[J].PLoS One, 2014, 9 (9):e106750.
[15] 何雁, 伏建峰, 王岚.溃疡性结肠炎血清中IL-6和IL-8水平分析[J].西北国防医学杂志, 2014, 35 (3):265-266.
-
计量
- 文章访问数: 28
- PDF下载数: 15
- 施引文献: 0